α-catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer

BJU International

Volumn 89, Issue 3, 2002, Pages 278-284

  Spermon, J R ^a   De Wilde, P C ^b   Hanselaar, A G J M ^b   Schaafsma, H E ^a   Ruijter, T E G ^b   Witjes, J A ^a   Van Moorselaar, R J A ^c  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alpha catenin; DNA content; Prognosis; Testicular cancer; Vascular invasion

Indexed keywords

ALPHA CATENIN; DNA; MONOCLONAL ANTIBODY;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER RISK; CANCER STAGING; CARDIOVASCULAR SYSTEM; CELL NUCLEUS; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; DNA DETERMINATION; FEULGEN STAINING; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; NON SEMINOMATOUS GERMINOMA; OCCULT BLOOD; ORCHIECTOMY; PARAAORTIC LYMPH NODE; POLYPLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; RETROPERITONEAL CANCER; RISK ASSESSMENT; TESTIS CARCINOMA; TUNICA ALBUGINEA;

ALPHA CATENIN; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PLOIDIES; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS;

EID: 0036174634     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.2417.x     Document Type: Article

References (40)

1. Medical Research Council prospective study of surveillance for stage I testicular teratoma
2. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-89
3. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours
4. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis
5. Staging relationships and outcome in early stage testicular cancer: A report from the Testicular Cancer Intergroup Study
6. Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer
7. Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor
8. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial
9. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma
10. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone
11. Prognosis and other clinical correlates of pathologic review in stage I and IIA testicular carcinoma: A report from the Testicular Cancer Intergroup Study
12. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer
13. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: Multivariate analysis of a prospective multicenter study
14. Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer
15. Complex cadherin expression in human prostate cancer cells
16. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer
17. E-cadherin and alpha-catenin expression in human esophageal cancer
18. Immunohistochemieal evaluation of alpha-catenin expression in human gastric cancer
19. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours
20. Expression of E-cadherin and catenins on testis tumor
21. Flow cytometry in genitourinary malignancies using paraffin-embedded material
22. Tissue-specific markers in flow cytometry of urological cancers: Cytokeratins in bladder carcinoma
23. Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors
24. Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors
25. Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors
26. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors
27. DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I
28. Predictive parameters of biologic behaviour of early stage nonseminomatous testicular germ cell tumors
29. Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors
30. Automated image analysis DNA cytometry to predict the pathological stage in clinical stage I nonseminomatous testicular germ cell tumors
31. Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications
32. DNA ploidy patterns in cervical intraepithelial neoplasia grade III, with and without synchronous invasive squamous cell carcinoma. Measurements in nuclei isolated from paraffin-embedded tissue
33. The use of light green and orange II as quantitative protein stains, and their combination with the Feulgen method for the simultaneous determination of protein and DNA
34. DNA cytometric and interphase cytogenetic analyses of paraffin-embedded hydatidiform moles and hydropic abortions
35. Testis risk and prognostic factors. The pathologist's perspective
36. Spermatic cord contamination in testicular cancer
37. Prognostic risk factors in low stage testicular germ cell tumors: Unanswered questions regarding clinically useful prognosticators for extratesticular disease
38. Stage I nonseminomatous germ cell testicular tumor: Prediction of metastatic potential by primary histopathology